Loading peptide…
PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Also known as: Cartalax
Cartalax is a short synthetic peptide (Ala-Glu-Asp-Gly) studied as a bioregulator for cartilage and connective tissue. It is part of the Khavinson short peptide bioregulator family.
Sign in to rate this peptide.
Cartalax is a tetrapeptide (AEDG-related, Ala-Glu-Asp-Gly) proposed to act epigenetically by interacting with DNA and influencing gene expression in chondrocytes and bone-marrow-derived cells. Research suggests it modulates expression of genes such as those involved in cartilage matrix synthesis and can influence stem cell differentiation toward chondrogenic and osteogenic lineages. It is also reported to affect apoptosis-related signaling, supporting tissue renewal in cartilage and musculoskeletal structures.